In addition, PIF induces the shedding of syndecans from the cell surface. Syndecans are involved in wound repair, metastasis of cancers, and embryonic development. These results suggest that PIF may play additional roles in the proinflammatory response observed in cancer cachexia but may also have a role without the cachectic process.
human umbilical vein endothelial cells; human pulmonary arterial endothelial cells; proteolysis-inducing factor; cachexia; inflammation PROTEOLYSIS-INDUCING FACTOR (PIF), a novel protein of 24 kDa, was initially identified as sulfated glycoprotein capable of triggering muscle proteolysis during the process of cancer cachexia (24) . PIF is capable of both inducing muscle protein degradation in isolated gastrocnemius muscle preparations and inducing weight loss (5, 23) . In addition, the presence of PIF in the urine of cancer cachexia patients correlates with weight loss of Ͼ2.8 kg/mo (29) . Comprehensive tissue screening in adults demonstrated that only skeletal muscle and liver exhibited substantial binding of PIF, leading us to explore the effects of PIF on transcriptional regulation in liver parenchymal cells.
We have recently demonstrated (26) that PIF is able to induce both the proinflammatory response and the acute-phase response in human hepatocytes, suggesting additional roles of PIF other than the degradation of skeletal muscle. PIF induced hepatocyte production of the proinflammatory cytokines interleukin (IL)-8 and IL-6, postulated as signals for the increase in muscle proteolysis during cachexia (3, 20) , and an induction of the acute-phase protein response (8, 21) . Induction of proinflammatory cytokines and acutephase proteins is the result of increased gene transcription, mediated by cis-activating promoter elements that are binding sites for cytokine-activating nuclear transcription factors, including nuclear factor (NF)-B and STAT3.
Because liver comprises a variety of cell types, and to further ascertain the function and signaling capacity of PIF, we have investigated the biological effect of this molecule on gene expression in a variety of endothelial cells. Liver endothelial cells were of initial interest, but these could not be obtained in sufficient purity from human liver isolations. We therefore employed endothelial cells from a variety of sources to test the hypothesis that PIF could influence transcriptional regulation and gene expression in endothelial cells from different sites. These cells included the liver endothelial cell line SK-HEP-1, primary human umbilical vein endothelial cells (HUVECs), and human pulmonary artery endothelial cells (HPAECs). We have investigated the effect of PIF on the expression of several proteins regulated by NF-B and have thus examined the effect of PIF on the activation of the NF-B transcriptional pathway. The NF-B/Rel family consists of five members and can form various homo-or heterodimer complexes in the cytosol (17) , where it remains inactive because of its association with inhibitory proteins of the inhibitory (I) B family, particularly IB␣. NF-B is activated by the phosphorylation, ubiquitination, and degradation of IB␣, allowing NF-B to translocate to the nucleus. Activation of NF-B is central to the regulation of many genes, including proinflammatory cytokines and cell surface markers (4). Here we describe the effect of PIF on the induction of the proinflammatory cytokines IL-8 and IL-6, the cell surface adhesion molecules intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM), and the reduction in the expression of the transmembrane proteolglycans syndecan-1 and syndecan-2 in endothelial cells.
MATERIALS AND METHODS
Reagents. DMEM, penicillin/streptomycin, L-glutamine, and FCS were obtained from Life Technologies (Life Technologies, Inchinan, UK). Tumor necrosis factor (TNF)-␣ and IL-6 were obtained from R&D Systems (Oxon, UK). Protease inhibitor tablets were obtained from Boehringer Mannheim (Lewes, UK). Enzyme-linked immunosorbent assay (ELISA) kits were obtained from CLB (Eurogenetics UK, Hampton, UK). Antibodies for flow cytometry were obtained from the endothelial section of the Sixth International Workshop on Human Leukocyte Differentiation Antigens with the following clone names: B-B42, B-B4, 10H4, 2G7Hu 8/4, and 51-10C9. ICAM-1 antibody was obtained from Beckman Coulter (Beckman Coulter, High Wycombe, UK). Lipopolysaccharide (LPS) was derived from Escherichia coli 0127:B8 Sigma (Sigma, Poole, Dorset, UK). SK-HEP-1 cells were obtained from ECACC (Porton Down, UK). HUVECs, HPAECs, and endothelial cell basal medium were obtained from Biowhittaker. All other reagents were purchased from Sigma except the Pierce chemiluminescent system (Perbio, Cheshire, UK). PIF was purified at Astra-Zeneca (Macclesfield, UK) from the urine of pancreatic cancer patients with cachexia, as described previously (23, 24) . Column purification procedures were employed to avoid endotoxin contamination, and purified material was checked at each stage for endotoxin contamination. A Western blot showing native, purified PIF alongside recombinant PIF from a mammalian expression system is shown in Fig. 1 .
Cell culture. Cells were grown in tissue culture flasks until 95% confluency was reached. They were harvested using trypsin-EDTA, centrifuged at 500 g for 5 min, and resuspended in cell medium. Cells were then seeded at 1 ϫ 10 6 /ml into 6-or 96-well culture plates in medium containing 10% FCS and allowed to rest for 24 h before commencing experiments. Cells were treated in these wells with either TNF-␣, LPS, or PIF for 30 min or 24 h. Supernatants were stored for ELISA analysis, and cells were used for either nuclear and cytoplasmic protein extraction or staining with antibodies for flow cytometric analysis.
Nuclear and cytoplasmic protein extraction. Extracts were prepared according to the method of Johnson et al. (15) , and all buffers contained protease inhibitor cocktail tablets (Boehringer Mannheim). All extraction procedures were performed on ice with ice-cold reagents. Briefly, cell monolayers in six-well tissue culture plates were washed two times with 150 mM PBS, pH 7.2. Cells were then scraped into 200 l of buffer A (10 mM HEPES, pH 7.9; 10 mM KCl; and 1.5 mM MgCl 2) and incubated for 15 min on ice. Lysis was achieved by the addition of 25 l of Nonidet P-40 in buffer A. Nuclei were pelleted by centrifugation at 500 g for 4 min, and the cytoplasmic supernatant was stored at Ϫ70°C. The pellet was extracted with 50 l of lysis buffer (30 mM HEPES, pH 7.9; 0.45 M NaCl; and 1 mM EDTA). After a 15-min incubation on a mixer at 4°C, the extract was centrifuged at 14,000 g at 4°C. The supernatant was diluted 1:1 with 20 mM HEPES (pH 7.9), 0.1 M KCl, 0.2 mM EDTA, and 20% glycerol. Protein was estimated by the Bio-Rad DC protein assay kit according to the manufacturer's instructions (Bio-Rad, Hercules, CA), and nuclear supernatants were stored at Ϫ70°C until used for electrophoretic mobility shift assays (EMSA).
EMSA. The transcription factor consensus oligonucleotides for the NF-B responsive element (5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј) and the surfactant protein (SP)-1-responsive element (5Ј-ATT CGA TCG GGG CGG GGC GAG-3Ј) were purchased from Promega (Southampton, UK). The probes were labeled with [␥-32 P]ATP using T4 polynucleotide kinase (Promega) and purified on Sephadex G-25 (Pharmacia) spin chromatography columns. For the binding reaction, nuclear extract (1 g of protein) was incubated in a 10-l volume with 2 l of EMSA binding buffer [20% glycerol, 5 mM MgCl 2, 250 mM NaCl, 2.5 mM EDTA, 2.5 mM dithiothrietol, 50 mM Tris ⅐ HCl (pH 7.5), and 0.25 mg/ml poly(dIdC) ⅐ poly(dI-dC)] and 1 l ␥-32 P-labeled probe according to manufacturer's instructions (Promega). The specificity of the binding reaction was determined by coincubating duplicate samples with either unlabeled NF-B or the nonspecific SP-1 oligonucleotide probe or an anti-NF-B p65 antibody (Insight Biotechnology, Santa Cruz, CA). Protein-nucleic acid complexes were resolved using a nondenaturing polyacrylamide gel consisting of 4% acrylamide gel run in 5 mM Tris (pH 8.3) for 3 h at 200 V. Gels were transferred to Whatman 3M paper (Whatman, Clifton, NJ), dried under a vacuum at 80°C for 1 h, and exposed to photographic film at Ϫ70°C with an intensifying screen. g). Detection of the native and recombinant glycoprotein was by rabbit polyclonal antibody directed against a short peptide sequence of PIF followed by anti-rabbit peroxidase conjugate and the chemiluminescent system. There is a slight difference in size between the two bands because of the more complex glycosylation of the native molecule compared with the recombinant molecule. Relative molecular weight is indicated on left.
Measurement of cytokines. IL-8 and IL-6 were measured using sandwich ELISA, as described previously (27) . Briefly, immunoplates were coated overnight with rabbit anti-human antibody to the specific protein. Plates were washed four times, sample supernatants were added to the wells, and the plates were incubated for 1 h at room temperature. Plates were washed four times, and peroxidase-conjugated rabbit anti-human secondary antibody was added. Plates were incubated for 1 h at room temperature and then washed four times. The substrate 3,3Ј,5,5Ј-tetramethylbenzidine was added for 30 min, and the reaction was stopped with 1 M sulfuric acid. The plates were read using a MR5000 ELISA plate reader (Dynatech, Billinghurst, UK), and sample concentrations were calculated using AssayZap (Biosoft, Cambridge, UK).
Flow cytometry. Cells were harvested from tissue culture plastic using Cell Dissociation solution (Sigma) and flow cytometry analysis performed as described previously (12) . Briefly, cells were washed two times in PBS and incubated at room temperature for 20 min in rabbit serum. Cells were washed again two times in PBS and incubated for 30 min at room temperature with the appropriate antibody. Cells were washed again two times in PBS and incubated for 30 min at room temperature with a secondary antibody conjugated with fluorescein isothiocyanate (Sigma). Cells were then analyzed by flow cytometry.
Statistical analysis. Unless otherwise stated, values are reported as means Ϯ SE. Data were analyzed by ANOVA followed by the Student's t-test where appropriate. Twotailed tests were used on all occasions, and P values Ͻ0.05 were considered statistically significant.
RESULTS

NF-B activation. SK-HEP-1 cells, HUVECs, and
HPAECs were grown to subconfluency, and all cell types were treated with TNF-␣ (10 ng/ml) or PIF (10 and 100 ng/ml) in medium containing 10% serum. It has been postulated that PIF binds to albumin, and parallel experiments have been carried out in which cells were treated in the absence of FCS with no differences observed (data not shown). Cells were treated for 15, 30, and 60 min, and nuclear extracts were prepared to determine if NF-B activation occurred. Figure 2 shows that, in both SK-HEP-1 cells and HUVECs, NF-B was activated by both TNF-␣ and PIF at 30 min. However, PIF had no effect on NF-B activation in HPAECs (Fig. 2C) . Figure 2D shows a control EMSA to determine the specific NF-B band.
Proinflammatory cytokine release. The effect of PIF on the production of the NF-B-regulated cytokines IL-8 and IL-6 was investigated in SK-HEP-1 cells, HUVECs, and HPAECs after 24 h of exposure to PIF. Figure 3A shows the effects of TNF-␣ (10 ng/ml) and PIF (10 or 100 ng/ml) on IL-8 release in the cell supernatant in SK-HEP-1 cells, HUVECs, and HPAECs. TNF-␣ significantly induces IL-8 in all three cell types. IL-8 was also induced in SK-HEP-1 cells and HUVECs after treatment with PIF. PIF did not, however, induce IL-8 in HPAECs. Previous studies indicated that TNF-␣ had a minimal effect on IL-6 release from hepa- tocytes; thus, LPS was used as a positive control in endothelial cells. Figure 3 , B and C, shows the effects of LPS (10 g/ml) and PIF (10 or 100 ng/ml) on IL-6 release from SK-HEP-1 cells and HUVECs. PIF significantly induces the production of IL-6 in both cell types, and, although LPS (data not shown) was able to induce IL-6 in HPAECs, PIF had no effect.
Expression of adhesion molecules. The effect of PIF on ICAM-1 and VCAM expression was investigated in SK-HEP-1 cells, HUVECs, and HPAECs after 24 h of exposure to PIF (10 ng/ml). Figure 4 shows the effects of PIF on ICAM-1 and VCAM induction in SK-HEP-1 cells and HUVECs. PIF significantly increases ICAM-1 expression in both SK-HEP-1 cells and HUVECs but has no effect on HPAECs (data not shown). PIF also significantly increases VCAM expression in the SK-HEP-1 cells but has no effect on VCAM expression in either the HUVECs or HPAECs.
Syndecan expression. SK-HEP-1 cells, HUVECs, and HPAECs were exposed to PIF (10 ng/ml) for 24 h to determine the effect of PIF on cell surface expression of a number of molecules. One of the most significant observations was that syndecan-1 and syndecan-2 were decreased in both SK-HEP-1 cells (Fig. 5A) and HUVECs (Fig. 5B) exposed to PIF. LPS had no effect on the expression of syndecans in either SK-HEP-1 cells or HUVECs (data not shown). Syndecan levels were not altered by PIF in HPAEC cells. Effect of TNF-␣ (10 ng/ml) and PIF (10 or 100 ng/ml) on IL-8 release in SK-HEP-1 cells, HUVECs, and HPAECs at 24 h (A), LPS (10 g/ml) and PIF (10 or 100 ng/ml) on IL-6 release in SK-HEP-1 cells at 24 h (B), and LPS (10 mg/ml) and PIF (10 or 100 ng/ml) on IL-6 release in HUVECs at 24 h (C). * P Ͻ 0.05, ** P Ͻ 0.01, and *** P Ͻ 0.001.
DISCUSSION
PIF has no homology with known cytokine families and is distinguished from other cytokines by the ability to accelerate the breakdown of skeletal muscle both in vitro and in vivo (5, 24) . There is some evidence that the primary role of PIF is in developmental regulation (26) , and the molecule does not appear to be expressed in the normal adult, although this requires further investigation. However, the glycoprotein appears to be aberrantly reexpressed by some tumor cells and has been shown to be present in the urine of pancreatic cancer patients with a weight loss of Ͼ2.8 kg/mo (29) . These patients suffer from cachexia, characterized by massive weight loss resulting from the degradation of skeletal muscle, loss of lean and fat body mass, increased energy expenditure, and an increase in the proinflammatory and acute-phase response (8, 28) . Moreover, screening of adult tissues suggested that the major binding sites for PIF in adult tissue were skeletal muscle and liver. We have previously shown (26) that PIF may contribute to the acute-phase response and the proinflammatory response because of its ability to induce NF-B and STAT3 activation in human hepatocytes. This induction is associated with an increase in IL-8, IL-6, and C-reactive protein production, an increase in ICAM-1 expression, and a decrease in transferrin production. This suggests that PIF may play a crucial role in the inflammatory state associated with some types of cancer in addition to its postulated role in the degradation of skeletal muscle. Here we show that PIF is able to activate both liver endothelial cells (SK-HEP-1 cells) and HUVECs but not HPAECs. Endothelial cells form a physical and interactive barrier between the blood and tissues and are important in the pathophysiology of many conditions. Circulating factors such as TNF-␣ are able to alter endothelial function, including the synthesis and release of cytokines, such as IL-8 and IL-6, and expression of cell surface adhesion molecules (16) . Our data show that PIF induces the activation of NF-B in both SK-HEP-1 cells and HUVECs (but not the HPAECs), resulting in the release of the proinflammatory cytokines IL-8 and IL-6. NF-B activation is central to the regulation of many genes, including those involved in growth control (18) and inflammatory processes (4). IL-8 and IL-6 influence the inflammatory response, resulting in local activation of cells and chemoattraction, and these results suggest that PIF may play a role in endothelial gene regulation.
In addition to the induction of proinflammatory cytokine production, this study demonstrates that PIF can induce the expression of both ICAM-1 in SK-HEP-1 cells and HUVECs and VCAM in SK-HEP-1 cells. Neither ICAM-1 nor VCAM expression was increased in the HPAECs after exposure to PIF. Both ICAM-1 and VCAM are cell surface expression molecules that can be upregulated by proinflammatory cytokines such as TNF-␣ to mediate the interaction between cells (7). One of the key features of the inflammatory response is the local accumulation of leukocytes, the type of which depends on the nature of the inflammatory stimuli and the expression of adhesion molecules, such as ICAM and VCAM on the endothelial surface. Migrating monocytes express leukocyte function-associated antigen-1 and ␣ 4 -integrin (CD49d), which are ligands for expression molecules such as ICAM-1 and VCAM, and the presence of these two adhesion molecules allows selective adherence and accumulation of monocytes on the endothelial cell layer (7). Accumulation of monocytes in the liver would further enhance the proinflammatory response, especially since binding of monocytes to the endothelium results in further activation of endothelial cells (16) . In addition, preliminary data show that PIF has an effect on NF-B activation and, hence, the proinflammatory response in both Kupffer cells and circulating monocytes. These results therefore suggest that PIF produced by some cancers plays a role in the proinflammatory response that accompanies the cancer. The results also suggest that there is some differential specificity of action of PIF on endothelial cells at different sites.
Although the present work has examined resting endothelial cells, the effect of shear stress on the production of cytokines is important. Shear stress can profoundly influence cytokine expression by the endothelium, but the effect is highly dependent on the magnitude of the shear stress exerted. Normal fluid shear stress appears to be protective against atherosclerosis and suppresses, for example, IL-8 production in HUVECs (25) . However, high shear stress involves the generation of platelet-derived microparticles and causes activation of endothelial cells with the production of IL-8, IL-1␤, and IL-6 (19) . It is difficult to predict the effect of PIF on endothelium in the presence of normal or abnormal shear stress, and the effects may also vary depending on the origin of the endothelial cells.
It is of considerable interest that PIF induces syndecan shedding from the SK-HEP-1 cell line and HUVECs, but not from the HPAECs, whereas LPS has no effect on syndecan expression. The syndecans are a family of transmembrane proteoglycans that are important in several signal transduction cascades, particularly in the regulation of cell proliferation (30) . Expression of syndecans is highly regulated, and there are distinct patterns of expression in individual cell types and tissues and during developmental stages. Expression of the syndecans can be modified in pathological situations such as wound healing. Syndecans are able to interact with a number of molecules, including adhesion molecules, growth factors, lipid metabolism proteins, and pathogens, and can be involved in proliferation, differentiation, adhesion, migration, lipid metabolism, and infection (30) .
Although little is known about syndecan shedding, it is thought to be highly regulated, stimulated by receptor activation and cell stress. Cleavage of the core protein from the cell surface appears to be controlled by the intracellular signaling pathway. The shed syndecan is thus rendered soluble and can exert extracellular effects, such as modulating the activity of heparinbinding molecules, like growth factors and cytokines, to promote tissue repair. However, excess shedding can interfere with repair and also with the host defense mechanism. This indicates that the shedding of syndecan is facultative in tissue repair and host defense (22, 30) . In addition, it has been reported (14) that syndecan-1 can be used as a prognostic marker in cancer patients, since there appears to be a correlation between the loss (shedding) of syndecan-1 expression and mortality. Development of malignant epithelial tumors is associated with reduced intracellular adhesion, distribution, differentiation, and changes in the composition of the basement membrane, suggesting that expression and function of cell adhesion molecules could also change during malignant transformation. Loss of syndecan-1 is involved in uncontrolled proliferation, decreased adhesion, and disturbed differentiation of tumor cells. Hence. secretion of PIF may contribute to the pathogenesis/metastasis of a tumor by inducing a decrease in the expression of syndecans.
The normal role of PIF is unknown, but it is unlikely to be a protein produced only by tumor cells. In this study, it is clear that PIF does not affect transcriptional regulation in all endothelial subtypes. PIF induced responses in both SK-HEP-1 cells and HUVECs but not in HPAECs, indicating there may be some specialization in receptor expression by endothelial subtypes, possibly because of the normal role of PIF. In addition, VCAM expression was only upregulated in SK-HEP-1 cells. One clue to the normal role of PIF arises from the observation (unpublished data; see Ref. 5 ) that there is a peak of expression in the mouse embryo at embryonic day 8.5, suggesting an involvement in development. In addition, syndecan-1 is expressed at embryonic day 8.5 (2), apparently concurrent with the peak of PIF expression. The most dramatic changes in syndecan expression occur during development, and these are associated with morphological transitions, cell differentiation, and changes in tissue organization (2, 14, 22, 30) . Embryogenesis is a dynamic process, and tissue-specific expression of PIF and syndecans during development may be coordinated through expression of ligands and coreceptors. In this study, the addition of PIF to endothelial cells results in a decrease in syndecan expression, suggesting a possible role in development through the induction of shedding of the functioning ectoderm portion of syndecan, allowing movement to the areas necessary for growth and development.
Furthermore, vascular development, in particular umbilical arteries, occurs at embryonic day 8.5 (10), again concurrent with PIF expression, and this is followed by organization of endothelial cells at embryonic day 9. 25 . It has been demonstrated that organization of endothelial cells to form into vessels requires cell-tocell adhesion, requiring cell surface proteins such as cadherin and ICAM. ICAM is also reported to be expressed in cells during development, being involved in morphogenesis (1) .
Activation of NF-B is also vital during development and cell growth. NF-B has been shown to be required for growth of tissues, particularly in the developmental phases, and its ability to regulate growth control through the regulation of cyclin D may be related to its cell survival properties (11) . NF-B is involved in cell cycle regulation (13) by its ability to promote transition from the G 1 phase to the S phase in mouse embryonic fibroblasts. NF-B activation during the early phases of the cell cycle is therefore necessary for regulation of both growth and differentiation (9) . In addition, preliminary data indicate that PIF induces activation of the transcription factor hepatocyte nuclear factor (HNF)-4. HNF-4 belongs to a family of transcription factors that are involved in cell proliferation and differentiation; HNF-4 is observed during morphogenesis and development of the liver, at embryonic day 8.5 (6) . Again, this is concurrent with PIF expression. The identity of the receptor for PIF remains undefined, and the reasons for continued expression of the receptor in adult tissues are still unclear. The heavily glycosylated nature of PIF may suggest that it can interact with a number of cell surface structures to induce signaling. This is clearly an area for future investigation.
In conclusion, PIF appears to have several important roles, including skeletal muscle proteolysis during cachexia. We have demonstrated that PIF is also able to induce the proinflammatory and acute-phase response in human hepatocytes. Here we show that the action of PIF on liver endothelial cells and HUVECs is to activate NF-B, resulting in both the production of proinflammatory cytokines and modulation of the expression of adhesion molecules. It is therefore probable that, during cachexia, PIF induces a local inflammatory response in the liver by increasing hepatocyte and endothelial proinflammatory production, which attracts monocytes. An increase in endothelial adhesion molecules allows leukocytes, such as monocytes, to adhere and thus contribute to inflammation. In addition, the combined increase in IL-8 and IL-6 release from both the endothelial cells and hepatocytes may contribute to the acute-phase response. PIF may therefore be a therapeutic target in the treatment of cancer cachexia. Perhaps more interesting, however, are the differential effects of PIF on endothelial subtypes in view of the putative role of this molecule in embryonic development.
